Tech Company Financing Transactions

Deep Blue Medical Funding Round

On 4/21/2026, Deep Blue Medical raised $5.6 million in Series A funding from private investors.

Transaction Overview

Company Name
Announced On
4/21/2026
Transaction Type
Venture Equity
Amount
$5,600,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support its expansion into aesthetic and breast applications, and deepen already extensive relationships with key opinion leaders and hospital systems.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
701 West Main Street 410
Durham, NC 27701
USA
Email Address
Not Recorded
Overview
Deep Blue Medical Advances has developed a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Our surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, several additional products are in development, including an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.
Profile
Deep Blue Medical LinkedIn Company Profile
Social Media
Deep Blue Medical Company Twitter Account
Company News
Deep Blue Medical News
Facebook
Deep Blue Medical on Facebook
YouTube
Deep Blue Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bill Perry
  Bill Perry LinkedIn Profile  Bill Perry Twitter Account  Bill Perry News  Bill Perry on Facebook
Chief Medical Officer
Howard Levinson
  Howard Levinson LinkedIn Profile  Howard Levinson Twitter Account  Howard Levinson News  Howard Levinson on Facebook
Chief Operating Officer
Lou Fuqua
  Lou Fuqua LinkedIn Profile  Lou Fuqua Twitter Account  Lou Fuqua News  Lou Fuqua on Facebook
VP - R & D
David Ruppert
  David Ruppert LinkedIn Profile  David Ruppert Twitter Account  David Ruppert News  David Ruppert on Facebook
VP - Sales
Dave Murrell
  Dave Murrell LinkedIn Profile  Dave Murrell Twitter Account  Dave Murrell News  Dave Murrell on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/21/2026: Exergy3 venture capital transaction
Next: 4/21/2026: Bladex venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary